Endostatin Binds to Blood Vessels in Situ. Independent of Heparan Sulfate and Does Not Compete for Fibroblast Growth Factor-2 Binding
Open Access
- 31 July 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (1), 71-76
- https://doi.org/10.1016/s0002-9440(10)65101-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Zinc-Binding of Endostatin Is Essential for Its Antiangiogenic ActivityBiochemical and Biophysical Research Communications, 1998
- Zinc-dependent dimers observed in crystals of human endostatinProceedings of the National Academy of Sciences, 1998
- Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatinThe EMBO Journal, 1998
- Crystal structure of the angiogenesis inhibitor endostatin at 1.5AresolutionThe EMBO Journal, 1998
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Identification of Three N-terminal Ends of Type XVIII Collagen Chains and Tissue-specific Differences in the Expression of the Corresponding TranscriptsJournal of Biological Chemistry, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast DifferentiationScience, 1991
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991